Article Details

IFM Therapeutics Announces Dosing of First Subjects in Phase 1 Healthy Volunteer Study of Lead ...

Retrieved on: 2019-03-27 19:03:45

Tags for this article:

Click the tags to see associated articles and topics

IFM Therapeutics Announces Dosing of First Subjects in Phase 1 Healthy Volunteer Study of Lead .... View article details on HISWAI:

Excerpt

<div>... preeminent scientists and physicians following the sale of IFM Therapeutics, Inc (originally founded by Gary Glick and <b>Atlas Venture</b>) to Bristol-Myers ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up